Microchips implanted in the human body are real, already in clinical use, and overwhelmingly medical in purpose. They stimulate damaged brain tissue, restore partial vision, pace the heart, deliver drugs on schedule, and monitor blood sugar. A smaller number of people have voluntarily implanted tiny radio-frequency chips in their hands for unlocking doors or making contactless payments. None of these devices track your location, none broadcast a signal on their own, and the gap between what implanted chips actually do and what many people fear they do is enormous.
Implants That Treat Disease
The longest-running and most common microchip-style implants in humans are therapeutic devices embedded to manage chronic illness. Deep brain stimulators, for instance, deliver electrical pulses to specific regions of the brain in people with advanced Parkinson’s disease. These systems are now considered a standard intervention at later disease stages, though researchers continue to improve them. Conventional deep brain stimulation runs continuously, which shortens battery life and can cause side effects. Newer adaptive designs use closed-loop feedback to deliver pulses only when brain signals indicate they are needed, reducing unwanted stimulation and extending the device’s lifespan.1PubMed. Toward adaptive deep brain stimulation in Parkinson’s disease: a review
Cardiac implants follow a similar trajectory. Leadless pacemakers, implantable loop recorders that monitor heart rhythm, and pressure sensors placed directly in the pulmonary artery are now widely used for treating and monitoring advanced heart conditions. These devices have been shown to improve patient outcomes significantly, and because they are small and self-contained, they avoid some of the complications associated with older pacemaker designs that relied on wires threaded through veins.2PubMed Central. Imaging features of leadless cardiovascular devices
Retinal implants represent one of the more dramatic applications. Patients with retinitis pigmentosa, a degenerative eye disease that progressively destroys photoreceptors, have received silicon microchips placed beneath the retina. One early study implanted a chip containing roughly 5,000 tiny light-powered electrodes in the eyes of six patients and found visual function improvements in all of them during follow-up. No signs of rejection, infection, or retinal detachment appeared. Researchers also observed an unexpected benefit: vision improved in areas of the retina far from where the chip sat, suggesting the device might trigger a broader protective effect on surrounding tissue.3PubMed. The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa Later-generation retinal implant systems have continued to refine this approach for people with end-stage disease.4Ophthalmology. Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa
Brain-Computer Interfaces for Paralysis
Brain-computer interfaces, or BCIs, translate neural signals into digital commands, letting a person with severe paralysis control a cursor, type, or operate assistive devices using thought alone. Most BCI research has required open-brain surgery to place electrode arrays directly on or inside the brain. A newer approach sidesteps that entirely: an endovascular BCI is threaded through a blood vessel to reach the motor cortex, much the way a cardiologist threads a stent through arteries to the heart.
The first human trial of this endovascular approach enrolled four patients with severe paralysis. The study found that it was possible to record usable neural signals from inside a blood vessel adjacent to the brain’s motor area, without ever opening the skull. The safety profile was favorable, and the researchers concluded that endovascular access could promote wider and faster adoption of BCI technology for people who need it.5PubMed Central. Assessment of Safety of a Fully Implanted Endovascular Brain-Computer Interface for Severe Paralysis in 4 Patients This matters because one of the biggest barriers to BCI adoption has always been the risk and invasiveness of brain surgery. If effective BCIs can be placed through a vein, the pool of patients willing and able to receive them grows considerably.
Implantable Drug Delivery and Glucose Monitoring
Another branch of implantable microchip technology focuses on releasing drugs inside the body on a controlled schedule. The concept addresses a real clinical problem: many potent medications, especially proteins and peptides used in hormone therapy or cancer treatment, break down in the stomach and have to be injected frequently. An implantable microchip can store multiple individual doses in tiny sealed reservoirs and release them at programmed intervals, making pulsatile or continuous delivery possible without repeated needle sticks.6PubMed. Implantable microchips for controlled drug delivery More recent work has refined these devices using micro-fabrication techniques to improve how precisely drugs are administered and to boost patient compliance, since the patient no longer has to remember daily injections or endure them.7PubMed. Implantable microchip: the futuristic controlled drug delivery system
Glucose monitoring is a related application. People with diabetes currently rely on either finger-prick blood tests or wearable continuous glucose monitors stuck to the skin. Researchers are developing fully implantable electromagnetic sensors that sit beneath the skin and detect changes in blood glucose indirectly, by measuring shifts in the electrical properties of the fluid surrounding cells as sugar levels rise and fall. Early proof-of-concept experiments in animal models showed a good correlation between the sensor’s readings and actual blood glucose during controlled testing.8Scientific Reports. Subcutaneously implantable electromagnetic biosensor system for continuous glucose monitoring The advantage of a fully implanted sensor over skin-worn patches is durability and convenience: no adhesive failures, no weekly replacements, and no visible hardware. The trade-off is that surgical placement and calibration add complexity.
Voluntary Consumer Implants
Outside the medical world, a growing subculture of biohackers and early adopters have had small radio-frequency identification (RFID) or near-field communication (NFC) chips injected into the webbing between their thumb and index finger. These chips are passive, meaning they contain no battery and emit no signal on their own. They only transmit a short string of data when held within a few centimeters of a compatible reader. The technology is the same as what powers contactless payment cards and office badge systems.9PubMed Central. Biohacking and Chip Implantation in the Human Hand: An Introduction
In practical terms, someone with a hand-implanted RFID chip can wave their hand over a door lock or a payment terminal. A few companies in Sweden and elsewhere have offered these implants to employees as a replacement for key cards. The chips cannot track your movements. They have no GPS capability. They store a simple identifier, and someone would have to hold a reader directly against your hand to read it. For most people, the novelty wears off quickly when they realize their phone already does the same thing more flexibly.
How Implanted Devices Get Power
One of the biggest engineering challenges with any implanted electronic device is keeping it powered without a bulky battery that eventually dies and requires surgery to replace. Multiple wireless power transfer strategies have been developed to address this. Inductive coupling, where an external coil transmits energy through the skin to an internal coil, is the most established method and is already used in cochlear implants and some neurostimulators. Magnetic resonance coupling, capacitive coupling, and newer approaches using acoustic (ultrasound) or optical energy are all under active investigation for different types of implants.10PubMed Central. Wireless Power Transfer Techniques for Implantable Medical Devices: A Review
The choice of power method depends on where in the body the device sits, how much energy it needs, and how deep it is. Deep brain stimulators, capsule endoscopes, pacemakers, and cardiac monitoring sensors each have different power demands and tissue environments. Wireless power transfer allows some of these devices to operate with smaller or no internal batteries, which shrinks the implant and can extend its useful life.11IET Power Electronics. Near‐field wireless power transfer used in biomedical implants: A comprehensive review
One particularly inventive approach is “neural dust,” a system of millimeter-scale sensors that use ultrasonic backscatter for both power and communication. In animal experiments, these tiny devices successfully recorded nerve and muscle signals from rats without any battery or wired connection. The concept points toward a future where implanted sensors could be so small they essentially disappear into tissue.12Neuron. Wireless Recording in the Peripheral Nervous System with Ultrasonic Neural Dust
Devices That Dissolve After Use
A newer class of implantable electronics is designed to do its job and then dissolve harmlessly in the body, eliminating the need for a second surgery to remove it. These “transient” electronics are built from materials like silicon, tungsten, and silicon dioxide that break down safely in biological fluids over a controlled timeframe.13PubMed Central. Materials and processing approaches for foundry-compatible transient electronics The concept has clear appeal for postoperative care, where a sensor might monitor a surgical site for infection or a stimulator might promote healing for a few weeks before simply disappearing.14Advanced Functional Materials. Transient Implantable Electronics for Postsurgery Preventive Medicine
The materials science behind transient electronics has advanced to the point where standard semiconductor manufacturing processes can produce water-soluble electronic components. That means these devices could eventually be made at scale using existing chip foundries, rather than requiring exotic custom fabrication. Researchers have demonstrated working transistors and circuits that dissolve completely in aqueous environments, with potential applications ranging from temporary biomedical implants to hardware that self-destructs for data security purposes.15PubMed. Advanced Materials and Systems for Biodegradable, Transient Electronics
The Body’s Reaction to Foreign Objects
Any device implanted in the body triggers a foreign body response. The immune system recognizes the implant as non-self and gradually encases it in a fibrous capsule, a layer of scar tissue that can degrade the device’s performance over time. For a sensor, the capsule can act as a barrier that slows the diffusion of molecules the sensor is trying to detect. For a stimulator, it can increase the distance between the electrode and the target tissue, requiring higher power to achieve the same effect.
Recent work has attacked this problem with adhesive coatings that bond the implant surface directly to surrounding tissue. In animal experiments, adhesive-coated implants formed tight, conformal integration with organ surfaces and showed no observable fibrous capsule formation for up to 84 days across multiple organs, including the abdominal wall, colon, stomach, lung, and heart. Non-adhesive control implants, by contrast, developed substantial fibrous capsules on all organs tested.16Nature. Adhesive anti-fibrotic interfaces on diverse organs If these coatings translate to human use, they could dramatically extend the functional lifespan of implanted sensors and stimulators.
Real Security Concerns Versus Imagined Ones
The fear that an implanted chip could be used to track or surveil you misunderstands the technology. Passive RFID chips have no power source and no GPS receiver. They cannot broadcast your location. They transmit only when a reader is held within centimeters. But that does not mean implanted devices are free from security worries. The concerns are just different from the ones that dominate public imagination.
Medical devices that connect to wireless networks for data transmission or firmware updates have been shown to carry genuine cybersecurity vulnerabilities. Increased connectivity to hospital and home networks has exposed these devices to attack surfaces they were never designed to handle, and patient safety is the direct concern.17PubMed Central. Cybersecurity vulnerabilities in medical devices: a complex environment and multifaceted problem For consumer-grade RFID implants specifically, the VeriChip, which the FDA approved in 2004 as a way for doctors to access patient medical records, was shown to be vulnerable to cloning.18PubMed. FDA approves implantable chip to access medical records An attacker who scanned or eavesdropped on the chip’s signal could create a duplicate device that was indistinguishable from the original over the air.19Journal of the American Medical Informatics Association. The Security Implications of VeriChip Cloning The VeriChip product line eventually failed commercially, partly because the security and privacy concerns never received a satisfying answer.
The practical upshot: the security risk from an implanted chip is not that someone secretly tracks you. It is that someone standing next to you with the right equipment could copy your chip’s identifier. For medical implants, the risk is that a networked device could be tampered with remotely. Both are solvable engineering problems, but neither maps onto the surveillance narrative that dominates public worry.
Why Public Perception Is So Far Off
Surveys across multiple countries consistently find that people view microchip implants negatively, associating them with privacy violations and health risks. Perceived trust is one of the strongest predictors of whether someone would consider using an implant, and that trust is heavily shaped by concerns about privacy and technology safety. Worry about painful procedures and health complications further reduces how useful people think these devices could be.20Organizacija. Are we Ready to Use Microchip Implants? An International Cross-sectional Study
A significant portion of the distrust is fueled by conspiracy theories and misperceptions about what implanted devices can actually do. Opposition to insertable devices comes from multiple directions: misunderstandings about how the technology works, religious and moral objections, and broader suspicion of institutions. These misperceptions are not simply a matter of people lacking information. Research suggests that people can hold false beliefs about implants with a high degree of certainty and use those beliefs as evidence of being well-informed. The unfounded claim that COVID-19 vaccines contained tracking microchips, for example, gained extraordinary traction despite having no basis in reality.21Frontiers in Psychology. Socio-technical context for insertable devices Correcting these misperceptions with factual information is less effective than you might hope, because the beliefs are sustained by cognitive biases and reinforced by science fiction, media narratives, and social media rather than by an absence of accurate information.
What Happens When an Implant Needs to Come Out
Removing a subcutaneous microchip is usually a straightforward minor procedure. In animal research settings where RFID identification chips are routinely implanted, removal involves locating the chip (sometimes with the help of a small magnet), making a tiny incision of a few millimeters, extracting the chip with forceps, and closing the wound with tissue adhesive. In one standardized protocol, the entire process took only about eight minutes under anesthesia.22PubMed Central. Surgical removal of implanted microchips to correct MRI susceptibility artifacts in mice Human consumer-grade implants in the hand are similarly small, about the size of a grain of rice, and sit just beneath the skin. The removal process for people is comparable to a minor outpatient procedure.
Deeper medical implants like brain stimulators, retinal chips, or cardiac devices are a different story. These are placed surgically, often in delicate locations, and removal carries real risks. This is one reason biodegradable transient electronics are generating so much interest: if the device dissolves on its own once its therapeutic window has passed, you avoid the entire removal question. For devices that need to last indefinitely, like pacemakers, the focus is on extending battery life through wireless recharging and more efficient stimulation algorithms so that surgical battery replacements become less frequent.